Global Expression Vectors Market, By Host Type (Bacterial Expression Vectors, Mammalian Expression Vectors, Insect Expression Vectors, Yeast Expression Vectors, Other Expression Vectors), Application (Therapeutic Applications, Industrial Applications, Research Applications), End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Other End Users) – Industry Trends and Forecast to 2029.
Market Analysis and Size
Genetic engineering has revolutionized the world of medical science. Genetic engineering has carved the way for the innovations and this has led to the rising application of expression vectors. Injected genes in the target cells has been made easy with the discovery of expression vectors.
- Data Bridge Market Research analyses that the expression vectors market is expected to undergo a CAGR of 6.40% during the forecast period. This indicates that the market value, which was USD 337.39 million in 2021, would rocket up to USD 554.20 million by 2029. “Bacterial Expression Vectors” dominates the host type segment of the expression vectors market owing to the high transformation levels and simple transformation protocols. The market report curated by the Data Bridge Market Research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Expression vectors allow to clone a particular gene and express it in a host cell. Expression vectors is a plasmid engineered in the human body to treat a disease like diabetes. Expression vectors are engineered to introduce gene in the target cells.
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Host Type (Bacterial Expression Vectors, Mammalian Expression Vectors, Insect Expression Vectors, Yeast Expression Vectors, Other Expression Vectors), Application (Therapeutic Applications, Industrial Applications, Research Applications), End User (Pharmaceutical and Biotechnology Companies, Academic Research Institutes, Other End Users)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories Inc. (US), QIAGEN (Germany), Merck KGaA (Germany), TAKARA HOLDINGS Inc. (Japan), New England Biolabs (US), GenScript (US), Quest Diagnostics (US), Synbio Technologies (US), Addgene,Inc. (US), BD (US), OriGene Technologies, Inc. (US), InvivoGen (US), GeneCopoeia, Inc. (US), ATCC (US), tebu-bio (France), System Biosciences, LLC. (US), Sanofi (France), transOMIC (US), Genlantis Inc. (US), Macrogen, Inc. (South Korea) and Gene Bridges GmbH (Germany)
|
Expression Vectors Market Dynamics
Drivers
-
The rise in the prevalence of diseases
Surging prevalence of acute and chronic diseases and such as diabetes all around the globe is one of the major factors responsible for fostering growth in the market value. Diabetes is one of the highest prevailing diseases in individuals especially in the geriatric population base.
-
Research and development proficiencies
Rising expenditure for research and development proficiencies especially in the developed and developing economies pertaining to the medical instruments and devices will further create lucrative market growth opportunities. Research and development proficiencies being conducted pertaining to the technological advancements in for protein-based drugs (biologics) is also bolstering the market growth rate.
-
Government investments on healthcare infrastructure
The increase in the funding by the federal government is set to drive the market growth rate. Moreover, growth and expansion of healthcare industry being driven by both public and private players especially in the developing economies will create lucrative market growth opportunities. Moreover, growing initiatives by the government to provide the best of drugs and medical technologies against lifestyle diseases, infectious diseases, and genetic disorders will further carve the way for the growth.
Additionally, surge in the personal disposable income level, introduction of technologically driven products in hospitals, increasing investment for the development of advanced medical products and devices and rising geriatric population base, positively affect the market growth rate.
Opportunities
Furthermore, upsurge in the public-private funding for target research activities, increasing advancement in protein expression techniques, and rising product innovations and development owing to technological advancements all around the world will extend profitable opportunities for the market players in the forecast period of 2022 to 2029. Additionally, surging number of strategic collaborations, introduction of advanced technologies in genetics, molecular biology, and bioinformatics, growing number of hospitals and laboratories, and increasing per capita expenditure on health care will further expand the market's growth rate in the future.
Restraints/Challenges
On the other hand, high cost associated with the research and development proficiencies, limited infrastructural facilities and high cost associated with the therapy and high market consolidation are expected to obstruct market growth. Also, lack of favourable reimbursement scenario and technology penetration in the developing economies, availability of low-cost substitutes, stringent regulatory approvals, high cost of protein therapy and lack of suitable infrastructure in low- and middle-income countries are projected to challenge the market in the forecast period of 2022-2029.
This expression vectors market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the expression vectors market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Expression Vectors Market
COVID-19 has had a negative impact on the market. A halt put on the non-essential surgical procedures restricted the scope of growth for the market. Restrictions imposed pertaining to the movement further created hindrances for the market in this pandemic phase. However, with the relaxations ahead, the market is expected to bounce back.
Global Expression Vectors Market Scope
The expression vectors market is segmented on the basis of host type, application and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Host type
- Bacterial Expression Vectors
- Mammalian Expression Vectors
- Insect Expression Vectors
- Yeast Expression Vectors
- Other Expression Vectors
On the basis of host type, the expression vectors market is segmented into bacterial expression vectors, mammalian expression vectors, insect expression vectors, yeast expression vectors and other expression vectors. Bacterial expression vectors are further segmented into E.Coli expression vectors and other bacterial expression vectors. Mammalian expression vectors are further segmented into CHO expression vectors and other mammalian expression vectors. Insect expression vectors are further segmented into baculovirus expression vectors and other insect expression vectors. Yeast expression vectors are further segmented into K. Lactis expression vectors, pichia pastoris expression vectors, saccharomyces cerevisiae expression vectors and other yeast expression vectors.
Application
- Therapeutic Applications
- Industrial Applications
- Research Applications
On the basis of application, the expression vectors market is segmented into therapeutic applications, industrial applications, and research applications.
End user
- Pharmaceutical and Biotechnology Companies
- Academic Research Institutes
- Other End Users
On the basis of end user, the expression vectors market is segmented into pharmaceutical and biotechnology companies, academic research institutes and other end users.
Expression Vectors Market Regional Analysis/Insights
The expression vectors market is analysed and market size insights and trends are provided by country, host type, application and end user as referenced above.
The countries covered in the expression vectors market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the expression vectors market because of the strong base of healthcare facilities, rising investment from key players in the growth of the advanced devices, rising prevalence of chronic diseases, wider exposure to technologies and advancement in the research and development sector with high-tech infrastructure, presence of a large number of pharmaceutical companies and rising number of research activities in this region.
Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increase in government initiatives to promote awareness, rise in medical tourism, growing research activities in the region, amplified biotechnological activities with the help of private or government research organizations and the growing demand for quality healthcare in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The expression vectors market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for expression vectors market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the expression vectors market. The data is available for historic period 2010-2020.
Competitive Landscape and Expression Vectors Market Share Analysis
The expression vectors market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to expression vectors market.
Some of the major players operating in the expression vectors market are Thermo Fisher Scientific, Inc. (US), Promega Corporation (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories Inc. (US), QIAGEN (Germany), Merck KGaA (Germany), TAKARA HOLDINGS Inc. (Japan), New England Biolabs (US), GenScript (US), Quest Diagnostics (US), Synbio Technologies (US), Addgene,Inc. (US), BD (US), OriGene Technologies, Inc. (US), InvivoGen (US), GeneCopoeia, Inc. (US), ATCC (US), tebu-bio (France), System Biosciences, LLC. (US), Sanofi (France), transOMIC (US), Genlantis Inc. (US), Macrogen, Inc. (South Korea) and Gene Bridges GmbH (Germany) among others.
SKU-